Bioprocessing White Papers

  1. Deciphering The Complex Characteristics Of Nanomedicine 5/6/2026

    Gain deeper insight into nanomedicine characterization, showing how critical quality attributes, advanced analytics, and phase‑appropriate strategies drive safety, efficacy, and regulatory readiness.

  2. Innovations In API Manufacturing Of Small Molecule Drugs 5/6/2026

    Read how advances in people, processes, technology, materials, analytics, and sustainability are reshaping small‑molecule API manufacturing to reduce costs, scale efficiently, and meet future demand.

  3. Late‑Stage Progress In Excipients For Precision Nanomedicine 5/6/2026

    View late‑stage development and GMP manufacturing of novel excipients for nanomedicines, emphasizing regulatory rigor, process optimization, analytics, and scale‑up for lipid‑based delivery systems.

  4. Advancing Cell Culture Strategies To Accelerate Biologics Development 5/5/2026

    Integrated stable expression strategies accelerate biologics material generation, improving scalability, consistency, and early developability insights while reducing bottlenecks, variability, and risks in transitioning from discovery to manufacturing.

  5. Why Pharmaceutical Scientists Trust The Discovery Core Rheometer 5/1/2026

    Drug formulations demand more than single‑point viscosity data. Explore how rheology reveals stability, flow, and structural behavior across suspensions, topicals, and injectables.

  6. Expanding The Capabilities Of Targeted Integration 5/1/2026

    See the demonstration of precise, site‑specific integration of a 50 kb multi‑gene construct into human iPSCs, overcoming size limits of traditional genome‑engineering approaches.

  7. Fast Path To Market: Going From GMP1 To PPQ In Just 12 Months 4/30/2026

    Learn how focused optimization and coordinated execution helped overcome technical uncertainty and enable faster progression to market readiness.

  8. Standardized Extraction Protocol Per USP <665>: Bridging Regulatory Expectations And Industry Best Practices 4/29/2026

    View how to implement USP <665> extractables testing, align with global E&L standards, and apply risk-based strategies to ensure regulatory compliance and patient safety.

  9. Using Client Centricity As Fuel For Innovative Biologics Development And Manufacturing Solutions 4/23/2026

    Complex biologics require flexible development, advanced analytics, and quality by design. Learn how collaborative bioprocessing reduces risk, enables efficient scale‑up, and supports clinical success.

  10. Implementing Medium And High-Volume Drug Handling And Packaging Programs 4/23/2026

    Simplify the complexity of combination product development by partnering for integrated support across device design, industrialization, manufacturing, and final product assembly.